Iveta Nohavova

Iveta Nohavova

Auto-generated profile, based on publicly available information

Iveta Nohavova

Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in International Journal of Nursing Studies
Verified
Journal Article
Closed access
ACAndreas Charalambous
Andreas Charalambous
MWMary Wells
Mary Wells
PCPauline Campbell
Pauline Campbell
CTClaire Torrens
Claire Torrens
UÖUlrika Östlund
Ulrika Östlund
DKDaniel Kelly
Daniel Kelly

1 August 2018 in European Journal of Oncology Nursing
Verified
Journal Article
Closed access
MRMary Rezk-Hanna
Mary Rezk-Hanna
LSLinda Sarna
Linda Sarna
APAnne Berit Petersen
Anne Berit Petersen
MWMarjorie Wells
Marjorie Wells
INIveta Nohavova
Iveta Nohavova
SBStella Bialous
Stella Bialous

20 April 2018 in Addiction
Verified
Journal Article
Open access
PDF file
ODOmara Dogar
Omara Dogar
DBDeepa Barua
Deepa Barua
MBMelanie Boeckmann
Melanie Boeckmann
HEHelen Elsey
Helen Elsey
Razia Kaniz FatimaRazia Kaniz Fatima
Razia Kaniz Fatima
OCon behalf of the TB and Tobacco project consortium
on behalf of the TB and Tobacco project consortium
Background and aims: Tuberculosis (TB) patients who quit smoking have much better disease outcomes than those who continue to smoke. In general populations, behavioural support combined with pharmacotherapy is the most effective strategy in helping people to quit. However, there is no evidence for the effectiveness of this strategy in TB patients who smoke. We will assess the safety, effectiveness and cost‐effectiveness of cytisine—a low‐cost plant‐derived nicotine substitute—for smoking cessation in TB patients compared with placebo, over and above brief behavioural support.Design: Two‐arm, parallel, double‐blind, placebo‐controlled, multi‐centre (30 sites in Bangladesh and Pakistan), individually randomized trial.Setting: TB treatment centres integrated into public health care systems in Bangladesh and Pakistan.Participants: Newly diagnosed (in the last 4 weeks) adult pulmonary TB patients who are daily smokers (with or without dual smokeless tobacco use) and are interested in quitting (n = 2388).Measurements: The primary outcome measure is biochemically verified continuous abstinence from smoking at 6 months post‐randomization, assessed using Russell Standard criteria. The secondary outcome measures include continuous abstinence at 12 months, lapses and relapses; clinical TB outcomes; nicotine dependency and withdrawal; and adverse events.Comments: This is the first smoking cessation trial of cytisine in low‐ and middle‐income countries evaluating both cessation and TB outcomes. If found effective, cytisine could become the most affordable cessation intervention to help TB patients who smoke.

12 July 2017 in Journal of Advanced Nursing
Verified
Journal Article
Closed access
PDF file
PCPauline Campbell
Pauline Campbell
CTClaire Torrens
Claire Torrens
DKDaniel Kelly
Daniel Kelly
ACAndreas Charalambous
Andreas Charalambous
NDNuria Domenech‐Climent
Nuria Domenech‐Climent
MWMary Wells
Mary Wells

1 December 2016 in Central European Journal of Public Health
Verified
Journal Article
Closed access
EKEva Králíková
Eva Králíková
VFVladislava Felbrová
Vladislava Felbrová
SKStanislava Kulovaná
Stanislava Kulovaná
KMKateřina Malá
Kateřina Malá
INIveta Nohavová
Iveta Nohavová
LSLinda Sarna
Linda Sarna
Numbering about 90,000, nurses represent the largest group of health care providers in the Czech Republic. Therefore, nurses can make a significant impact in the treatment of tobacco dependence, particularly in applying brief interventions to smokers. During 2014, 279 nurses from the Czech Republic participated in an e-learning education programme consisting of two Webcasts with additional web-based resources about smoking cessation in relation to health and treatment options in daily clinical practice, particularly regarding brief intervention methods. Before viewing the e-learning programme, and three months after viewing it, the nurses completed a questionnaire documenting their interventions with smokers and their knowledge, attitudes and opinions regarding nurses' roles in smoking cessation. The responses in all of the following categories significantly improved: usually/always asking patients about smoking from 58% to 69% (OR 1.62, CI=1.14-2.29, p=0.007); recommendations to stop smoking from 56% to 66% (OR 1.46, CI=1.03-2.06, p=0.03); assessing willingness to quit from 49% to 63% (OR 1.72, CI=1.23-2.42, p=0.002); assisting with cessation from 21% to 33% (OR 1.85, CI=1.26-2.71, p=0.002); and recommending a smoke-free home from 39% to 58% (OR 2.16, CI=1.54-3.04, p<0.001). The increase in arranging follow-up from 7% to 10% did not constitute a statistically significant improvement, however, this finding is understandable in relation to the status of nurses in the Czech Republic. However, nurses' confidence in helping smokers to quit smoking, their senses of responsibility and determining the appropriateness of these interventions remains inadequate. The nurses' brief intervention skills improved significantly after the completion of the e-learning programme, even though reservations remain among this group. The systematic education of nurses aimed at smoking cessation intervention and analyzing their motivation for treatment may contribute to improved nursing care, and thus lead to a reduction of smoking prevalence in the general population.

30 March 2018 in BMJ Open
Verified
Journal Article
Open access
PDF file
MBMelanie Boeckmann
Melanie Boeckmann
INIveta Nohavova
Iveta Nohavova
ODOmara Dogar
Omara Dogar
EKEva Kralikova
Eva Kralikova
APAlexandra Pankova
Alexandra Pankova
DKDaniel Kotz
Daniel Kotz
Introduction: Tuberculosis (TB) remains a significant public health problem in South Asia. Tobacco use increases the risks of TB infection and TB progression. The TB& Tobacco placebo-controlled randomised trial aims to (1) assess the effectiveness of the tobacco cessation medication cytisine versus placebo when combined with behavioural support and (2) implement tobacco cessation medication and behavioural support as part of general TB care in Bangladesh and Pakistan. This paper summarises the process and context evaluation protocol embedded in the effectiveness–implementation hybrid design. Methods and analysis: We are conducting a mixed-methods process and context evaluation informed by an intervention logic model that draws on the UK Medical Research Council’s Process Evaluation Guidance. Our approach includes quantitative and qualitative data collection on context, recruitment, reach, dose delivered, dose received and fidelity. Quantitative data include patient characteristics, reach of recruitment among eligible patients, routine trial data on dose delivered and dose received, and a COM-B (‘capability’, ‘opportunity’, ‘motivation’ and ‘behaviour’) questionnaire filled in by participating health workers. Qualitative data include semistructured interviews with TB health workers and patients, and with policy-makers at district and central levels in each country. Interviews will be analysed using the framework approach. The behavioural intervention delivery is audio recorded and assessed using a predefined fidelity coding index based on behavioural change technique taxonomy. Ethics and dissemination: The study complies with the guidelines of the Declaration of Helsinki. Ethics approval for the study and process evaluation was granted by the University of Leeds (qualitative components), University of York (trial data and fidelity assessment), Bangladesh Medical Research Council and Bangladesh Drug Administration (trial data and qualitative components) and Pakistan Medical Research Council (trial data and qualitative components). Results of this research will be disseminated through reports to stakeholders and peer-reviewed publications and conference presentations. Trial registration number: ISRCTN43811467 ; Pre-results.